| Literature DB >> 26614042 |
Ligia Oliveira Gonçalves Morganti1, Márcio Cavalcante Salmito2, Juliana Antoniolli Duarte2, Karina Cavalcanti Bezerra2, Juliana Caminha Simões2, Fernando Freitas Ganança3.
Abstract
INTRODUCTION: Vestibular migraine (VM) is one of the most often common diagnoses in neurotology, but only recently has been recognized as a disease.Entities:
Keywords: Dizziness; Migraine disorders; Migrânea vestibular; Tontura; Transtornos de enxaqueca; Vertigem; Vertigo; Vestibular migraine
Mesh:
Year: 2015 PMID: 26614042 PMCID: PMC9449005 DOI: 10.1016/j.bjorl.2015.06.003
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Figure 1Diagnostic criteria.
Lempert T, Olesen J, Furman J, Waterston, Seemungal B, Carey J, et al. Vestibular migraine: Diagnostic criteria Consensus document of the Bárány Society and the International Headache Society. Rev Neurol (Paris). 2014;170:401–6.
General aspects of symptoms in patients with vestibular migraine.
| % | |||
|---|---|---|---|
| Yes | 48 | 67.6 | <0.001 |
| Sometimes | 13 | 18.3 | |
| No | 10 | 14.1 | |
| Daily | 17 | 22.1 | |
| Daily to weekly | 35 | 45.5 | |
| Weekly to monthly | 13 | 16.9 | <0.003 |
| <1×/month | 12 | 15.6 | |
| Yes | 25 | 80.6 | <0.001 |
| No | 6 | 19.4 | |
| Yes | 11 | 61.1 | >0.005 |
| No | 7 | 38.9 | |
Distribution of auditory symptoms in patients with vestibular migraine.
| Complaint | % | |
|---|---|---|
| Hearing loss | 14 | 17.94 |
| Tinnitus | 41 | 52.56 |
| Ear fullness | 23 | 29.48 |
| No complaint | 30 | 38.46 |
| Total | 78 | 100 |
Pure tone audiometry findings in patients with vestibular migraine.
| Type of finding | % | Right unilateral | Left unilateral | Bilateral | ||||
|---|---|---|---|---|---|---|---|---|
| % | % | % | ||||||
| CHL | 1 | 1.85 | 1 | 1.85 | 0 | 0 | 0 | 0 |
| MHL | 3 | 5.55 | 0 | 0 | 2 | 8.33 | 1 | 1.85 |
| SHL | 13 | 24.07 | 0 | 0 | 2 | 8.33 | 11 | 20.37 |
| Normal | 37 | 68.51 | ||||||
| Total | 54 | 100 | ||||||
CHL, conductive hearing loss; MHL, mixed hearing loss; SHL, sensorineural hearing loss.
Vectoelectronystagmography findings in patients with vestibular migraine.
| Type of finding | % | Right unilateral | Left unilateral | Bilateral | ||||
|---|---|---|---|---|---|---|---|---|
| % | % | % | ||||||
| Hyporeflexia | 5 | 10.20 | 1 | 2.04 | 1 | 2.04 | 3 | 6.12 |
| Hyperreflexia | 11 | 22.44 | 2 | 4.08 | 3 | 6.12 | 6 | 12.24 |
| Central | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Normal | 33 | 67.34 | ||||||
| Total | 49 | 100 | ||||||
Distribution of cervical vestibular-evoked myogenic potential results in patients with vestibular migraine.
| Cervical VEMP | % | |
|---|---|---|
| Increased latency | 0 | 0 |
| Altered asymmetry index | 3 | 17.64 |
| Normal | 14 | 82.35 |
| Total | 17 | 100 |
VEMP, vestibular-evoked myogenic potential.
Distribution of comorbidities in patients with vestibular migraine.
| Comorbidity | % | |
|---|---|---|
| SAH | 26 | 32.09 |
| Others | 26 | 32.09 |
| Dyslipidemia | 16 | 19.75 |
| Depression | 10 | 12.34 |
| Diabetes mellitus | 6 | 7.40 |
| Hypothyroidism | 6 | 7.40 |
| Epilepsy | 3 | 3.70 |
| No comorbidities | 32 | 39.5 |
| Total | 81 | 100 |
SAH, systemic arterial hypertension.
Metabolic assessment of patients with vestibular migraine.
| Laboratory | Mean | Median | CV (%) | Min | Max | CI | |
|---|---|---|---|---|---|---|---|
| Hb | 13.6 | 13.6 | 7 | 11.7 | 16.5 | 57 | 0.2 |
| LDL | 109.9 | 111 | 33 | 39.2 | 195 | 57 | 9.4 |
| HDL | 53.7 | 55 | 29 | 31 | 110 | 57 | 4.1 |
| Triglycerides | 121.7 | 107 | 52 | 32 | 309 | 57 | 16.5 |
| Fasting blood glucose | 94.9 | 90 | 16 | 75 | 149 | 57 | 4.0 |
| 30′ | 143.0 | 134 | 29 | 76 | 289 | 48 | 11.8 |
| 60′ | 130.2 | 117 | 41 | 65 | 298 | 47 | 15.2 |
| 90′ | 112.7 | 101 | 49 | 58 | 356 | 47 | 15.6 |
| 120′ | 114.9 | 100 | 50 | 53 | 371 | 49 | 16.0 |
| 180′ | 83.8 | 78 | 50 | 36 | 312 | 45 | 12.3 |
| Glycated Hb | 6.6 | 6.05 | 27 | 5.6 | 11.1 | 8 | 1.3 |
| Fasting insulin | 7.7 | 4.9 | 111 | 0.27 | 40.7 | 46 | 2.5 |
| 30′ | 63.3 | 50.4 | 98 | 2.6 | 403.3 | 44 | 18.2 |
| 60′ | 62.7 | 46.07 | 85 | 2.2 | 244.8 | 45 | 15.6 |
| 90′ | 59.2 | 37.1 | 103 | 1.13 | 246.8 | 44 | 17.9 |
| 120′ | 64.3 | 34.95 | 104 | 4.25 | 341.0 | 44 | 19.8 |
| 180′ | 23.4 | 11.08 | 127 | 2.16 | 156.6 | 43 | 8.8 |
| Creatinine | 0.71 | 0.71 | 24 | 0 | 1.01 | 38 | 0.05 |
Hb, hemoglobin; LDL, low-density lipoprotein; HDL, high-density lipoprotein.